PLoS ONE · 2013 · 98 citations · 57 references
Veterinary MedicineInfectious DiseasesPathobiologyMolecular DiagnosticsPrion DiseasesZoonotic Disease EpidemiologyAnimal Prion DiseasesAntigen Detection AssaysChronic Wasting DiseaseCreutzfeldt-jakob DiseasePrion Disease DiagnosisZoonotic Disease DiagnosisBlood Product SafetyHerd Health SurveillanceHigh-sensitivity AssaysHuman Safety RisksPrion Amplification AssaysPrion EpidemiologyPrion SurveillanceQuaking-induced Conversion Assays
Blood-borne transmission of infectious prions during the symptomatic and asymptomatic stages of disease occurs for both human and animal transmissible spongiform encephalopathies (TSEs). The geographical distribution of the cervid TSE, chronic wasting disease (CWD), continues to spread across North America and the prospective number of individuals harboring an asymptomatic infection of human variant Creutzfeldt-Jakob Disease (vCJD) in the United Kingdom has been projected to be ~1 in 3000 residents. Thus, it is important to monitor cervid and human blood products to ensure herd health and human safety. Current methods for detecting blood-associated prions rely primarily upon bioassay in laboratory animals. While bioassay provides high sensitivity and specificity, it requires many months, animals, and it is costly. Here we report modification of the real time quaking-induced conversion (RT-QuIC) assay to detect blood-borne prions in whole blood from prion-infected preclinical white-tailed deer, muntjac deer, and Syrian hamsters, attaining sensitivity of >90% while maintaining 100% specificity. Our results indicate that RT-QuIC methodology as modified can provide consistent and reliable detection of blood-borne prions in preclinical and symptomatic stages of two animal TSEs, offering promise for prionemia detection in other species, including humans.
57
A simple method of estimating 50 per cent end points
Hr Muench · Medical Entomology and Zoology · 1938 · 8.4K citations
Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion
C. A. Llewelyn, P. B Hewitt, RSG Knight et al. · The Lancet · 2004 · 1.1K citations
Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient
Alexander Peden, Mark Head, L Ritchie Diane et al. · The Lancet · 2004 · 854 citations